A recent human clinical trial showed that oral supplementation of Setria® glutathione (GSH) increased levels of GSH in the blood. The study found that the increase was in most cases dose and time dependent, and that levels returned to baseline after a one-month washout.
The researchers also examined immune function markers and found that cytotoxicity was enhanced more than two-fold for participants taking 1000mg daily for three months. These findings support claims of oral glutathione’s bioavailability as well as its potential to enhance immune function.
If the cognition market is to come to represent a proportion of the overall supplement market that is more indicative of the importance of brain health, ingredient suppliers must provide manufacturers with indisputable data demonstrating the efficacy of their products.
Heart disease is a rare case of a big problem with a clear solution: Lower LDL. In Pantesin, manufacturers have an ingredient with a 40-year history of doing just that.